OliX Pharmaceuticals, Inc (KOSDAQ:226950)
138,000
+4,400 (3.29%)
Nov 20, 2025, 3:30 PM KST
OliX Pharmaceuticals Market Cap
OliX Pharmaceuticals has a market cap or net worth of 2.69 trillion as of November 19, 2025. Its market cap has increased by 399.66% in one year.
Market Cap
2.69T
Enterprise Value
2.71T
Revenue
7.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
138,000.00
Market Cap Chart
Since July 18, 2018, OliX Pharmaceuticals's market cap has increased from 422.03B to 2.69T, an increase of 536.77%. That is a compound annual growth rate of 28.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 2.69T | 655.86% |
| Dec 30, 2024 | 355.53B | 52.22% |
| Dec 28, 2023 | 233.57B | -16.24% |
| Dec 29, 2022 | 278.86B | -50.37% |
| Dec 30, 2021 | 561.83B | -17.52% |
| Dec 30, 2020 | 681.17B | 146.02% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 41.83T |
| ALTEOGEN | 29.31T |
| SK Biopharmaceuticals | 10.20T |
| ABL Bio | 9.70T |
| Yuhan | 9.20T |
| Peptron | 7.30T |
| HLB Co., Ltd. | 6.53T |